News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Cardinal Health Latest News

Theranostics: Reimagining the standard of care

06/03/2021
 

By Tiffany Olson, president of Nuclear & Precision Health Solutions at Cardinal Health
 

From HealthCare Business News magazine:
 

Precision medicine is an area of healthcare that targets treatment for a well-defined patient population, with the goal of improving safety, efficacy and outcomes. Theranostics take the concept of precision medicine a step further, targeting care for individual patients. In fact, the field has been called the epitome of personalized medicine. Simply put, theranostics combine a diagnostic radiopharmaceutical and therapeutic radiopharmaceutical, which are tailored to the patient at the cellular level. 
 

https://www.dotmed.com/news/story/54838?utm_campaign=MagLink&utm_source=DMBusiness&utm_medium=print